Financial statements Recepto Pharma
Balance sheet of Recepto Pharma
Company age:
Age:
11 y. 4 d.
Share capital:
Share capital:
50 000 PLN
Balance sheet data of RECEPTO PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 1 190 013,69 | 1 107 141,99 | 994 613,46 | 1 010 539,44 | 928 423,58 | 821 792,13 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 1 190 013,69 | 1 107 141,99 | 994 613,46 | 1 010 539,44 | 928 423,58 | 821 792,13 |
| C. Share capital contributions (basic funds) | - | 0,00 | - | - | - | - |
| D. Own shares (stocks) | 0,00 | 0,00 | - | - | - | - |
| Total liabilities | 1 190 013,69 | 1 107 141,99 | 994 613,46 | 1 010 539,44 | 928 423,58 | 821 792,13 |
| A. Equity | -221 377,75 | -305 922,16 | -433 883,98 | -417 742,33 | -501 571,25 | -608 189,95 |
| B. Liabilities and provisions for liabilities | 1 411 391,44 | 1 413 064,15 | 1 428 497,44 | 1 428 281,77 | 1 429 994,83 | 1 429 982,08 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.